HQL
Tekla Life Sciences Investors
Price:
12.1
USD
Volume:
154,778
United States | Finance and Insurance
HQL Net Margin
As of 2025-05-16, the Net Margin of abrdn Life Sciences Investors (HQL) is 638.8%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
HQL Net Margin - Historical Value
| Date | Value |
|---|---|
| 2023-09-30 | 638.8% |
| 2022-09-30 | -3463.6% |
| 2021-09-30 | 2817.9% |
| 2020-09-30 | 3629.8% |
| 2019-09-30 | -2888.5% |
| 2018-09-30 | 1440.2% |
| 2017-09-30 | 4081% |
| 2016-09-30 | -827.1% |
| 2015-09-30 | 3068.2% |
| 2014-09-30 | 10144.3% |
HQL Net Margin - Peers Comparison